Evidence map›Paper›PMID 33906960›Full record

ArticleImmunoHorizons2021

Indole-3-Carbinol-Dependent Aryl Hydrocarbon Receptor Signaling Attenuates the Inflammatory Response in Experimental Necrotizing Enterocolitis.

Lila S Nolan, Belgacem Mihi, Pranjal Agrawal, Qingqing Gong, Jamie M Rimer, Shay S Bidani, Sarah E Gale, Martin Goree, Elise Hu, Wyatt E Lanik and 8 more

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Mechanisms underlying aryl hydrocarbon receptor-driven divergent macrophage function.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Lila S NolanDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-4185-2686
Belgacem MihiDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Pranjal AgrawalWashington University in St. Louis, St. Louis, MO.ORCID 0000-0002-9952-4888
Qingqing GongDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Jamie M RimerDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Shay S BidaniDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Sarah E GaleDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Martin GoreeDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-9871-1737
Elise HuDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Wyatt E LanikDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Elizabeth HuangDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Jennifer K BandoDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-1331-7424
Victoria LiuWashington University in St. Louis, St. Louis, MO.
Angela N LewisDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO.
Aiza BustosWashington University in St. Louis, St. Louis, MO.
Zerina HodzicDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA; and.ORCID 0000-0002-3971-8795
Marie L LauryGenome Technology Access Center, McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-5082-0336
Misty GoodDivision of Newborn Medicine, Washington University School of Medicine, St. Louis, MO; mistygood@wustl.edu.ORCID 0000-0002-0264-5721
Washington University in St. Louis · USUniversity of Pittsburgh Medical Center · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Training of the Pediatric Physician-ScientistT32HD043010 · NICHD · WASHINGTON UNIVERSITY · PI MARK E. LOWE · 2002 to 2026
$6.4M
Modulation of the Intestinal Immune Response in Necrotizing EnterocolitisR01DK118568 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2018 to 2022
$1.8M
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing EnterocolitisK08DK101608 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2014 to 2017
$584k
Immune Checkpoints for Intestinal Innate Lymphoid CellsK99DK118110 · NIDDK · WASHINGTON UNIVERSITY · PI BANDO, JENNIFER KAORU · 2019 to 2020
$182k
Aryl hydrocarbon receptor signaling in the pathogenesis of necrotizing enterocolitisR03DK111473 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2017 to 2018
$153k
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NICHD NIH HHS T32 HD043010NIDDK NIH HHS K08 DK101608NIDDK NIH HHS K99 DK118110NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK118568NIDDK NIH HHS R03 DK111473
6 · The paper itself

Abstract

Necrotizing enterocolitis (NEC) causes significant morbidity and mortality in premature infants; therefore, the identification of therapeutic and preventative strategies against NEC remains a high priority. The ligand-dependent transcription factor aryl hydrocarbon receptor (AhR) is well known to contribute to the regulation of intestinal microbial communities and amelioration of intestinal inflammation. However, the role of AhR signaling in NEC is unclear. Experimental NEC was induced in 4-d-old wild-type mice or mice lacking AhR expression in the intestinal epithelial cells or AhR expression in CD11c

Indexed as

AnimalsAnimals, NewbornBasic Helix-Loop-Helix ProteinsDisease Models, AnimalEnterocolitis, NecrotizingHumansIndolesInterleukin-1betaIntestinal MucosaMacrophagesMembrane ProteinsMiceMice, Inbred C57BLReceptors, Aryl HydrocarbonSignal TransductionBasic Helix-Loop-Helix Proteinsindole-3-carbinolIndolesInterleukin-1betaMembrane ProteinsReceptors, Aryl Hydrocarbon

Identifiers

PMID33906960
PMCPMC8173979
OpenAlexW3158361511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.